OBESITY, OVERWEIGHT, OR CHRONIC WEIGHT MANAGEMENT
Clinical trials for OBESITY, OVERWEIGHT, OR CHRONIC WEIGHT MANAGEMENT explained in plain language.
Never miss a new study
Get alerted when new OBESITY, OVERWEIGHT, OR CHRONIC WEIGHT MANAGEMENT trials appear
Sign up with your email to follow new studies for OBESITY, OVERWEIGHT, OR CHRONIC WEIGHT MANAGEMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New daily pill shows promise for weight loss in Mid-Stage trial
Disease control OngoingThis study tests an experimental daily pill called aleniglipron for weight loss in 220 adults with obesity or overweight who also have a weight-related health issue. Participants receive either the drug or a placebo for 36 weeks, with the option to continue on the drug for anothe…
Matched conditions: OBESITY, OVERWEIGHT, OR CHRONIC WEIGHT MANAGEMENT
Phase: PHASE2 • Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New pill could melt fat in people with obesity
Disease control OngoingThis study tests a new oral drug called aleniglipron (GSBR-1290) in 71 adults with obesity (BMI ≥30). Participants take the drug or a placebo daily for 40 weeks. Researchers measure changes in body fat, waist size, and weight using special scans. The goal is to see if the drug sa…
Matched conditions: OBESITY, OVERWEIGHT, OR CHRONIC WEIGHT MANAGEMENT
Phase: PHASE2 • Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC